Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Ares-Serono signs agreement with PowderJect for drug delivery system

Feb. 18, 1999

Scios signs drug screening and license agreement with Telik

Feb. 18, 1999

Aastrom cord blood therapy kit receives CE Mark approval

Feb. 17, 1999

Icos collaborates with Array BioPharma on new drug development

Feb. 16, 1999

New patent expands OSI's gene transcription patent estate

Feb. 15, 1999

Broad patent issues for Avigen's AAV vectors

Feb. 12, 1999

ICAgen obtains patent and exclusive rights to ion channel technology

Feb. 11, 1999

Dexemel drug delivery vehicle approved in the U.K.

Feb. 10, 1999

Nexell awarded U.S. patent for neutropenia therapy

Feb. 10, 1999

Novel gene delivery system available for licensing from NIH

Feb. 9, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 7, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...